We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SCNI market cap is 2.39M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 9k | 124k | 284k |
| Operating Income | -3.19M | -2.6M | -1.82M | -1.93M | -1.9M |
| Net Income | -3.52M | -3.76M | -2.33M | -2.16M | -2.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 12.68M | 40k | 0 | 9k |
| Operating Income | -78.35M | -55.47M | -34.83M | -11.06M | -9.71M |
| Net Income | -109.19M | -4.46M | -39.98M | -5.8M | -6.5M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Total Assets | 23.29M | 19.9M | 17.47M | 17.05M | 14.85M |
| Total Liabilities | 28.1M | 27.01M | 22.04M | 22.17M | 22.14M |
| Total Equity | -4.81M | -7.11M | -4.57M | -5.12M | -7.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Total Assets | 115.75M | 56.91M | 99.6M | 27.07M | 17.47M |
| Total Liabilities | 180.8M | 71.51M | 76.27M | 28.83M | 22.04M |
| Total Equity | -65.05M | -14.6M | 23.33M | -1.76M | -4.57M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Operating | -3.06M | N/A | -9.38M | -1.46M | -3.22M |
| Investing | -6k | N/A | -637k | -2k | -8k |
| Financing | N/A | N/A | 1.09M | 1.42M | 1.43M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | ILS (ILS) | USD (US$) | USD (US$) | |
| Operating | -77.06M | -72.54M | -24.48M | -7.27M | -9.38M |
| Investing | -7.2M | -5.94M | -361k | -836k | -637k |
| Financing | 85.21M | 13.72M | 67.78M | 6.78M | 1.09M |
| Market Cap | 2.39M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 837.31k |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 5.36 (66.09%) |
| Company Name | Scinai Immunotherapeutics Ltd |
| Address |
jerusalem biopark, 2nd floor, hadassah ein kerem campus jerusalem, jerusalem 7403618 |
| Website | https://www.biondvax.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
